{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:29:43Z","timestamp":1789118983227,"version":"build-2803163510"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KO 947\/20-1"],"award-info":[{"award-number":["KO 947\/20-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41380-026-03649-6","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:35:01Z","timestamp":1778646901000},"page":"5667-5680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7890-1349","authenticated-orcid":false,"given":"Nicolas","family":"HOERTEL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7517-9154","authenticated-orcid":false,"given":"Christiane","family":"M\u00dcHLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5325-9900","authenticated-orcid":false,"given":"Christian P.","family":"M\u00dcLLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9di","family":"CHAIEB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"SCHEER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"FAYAD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"S\u00c1NCHEZ-RICO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-1514","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"LIMOSIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8096-3987","authenticated-orcid":false,"given":"Johannes","family":"KORNHUBER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"3649_CR1","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299\u2013312.","journal-title":"Lancet"},{"key":"3649_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"3649_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7:137\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"3649_CR4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4088\/JCP.v61n0405","volume":"61","author":"RM Hirschfeld","year":"2000","unstructured":"Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry. 2000;61:4\u20136.","journal-title":"J Clin Psychiatry"},{"key":"3649_CR5","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023;28:3243\u201356.","journal-title":"Mol Psychiatry"},{"key":"3649_CR6","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. AJP. 2006;163:1905\u201317.","journal-title":"AJP"},{"key":"3649_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/104012371402600310","volume":"26","author":"K Trevino","year":"2014","unstructured":"Trevino K, McClintock SM, McDonald Fischer N, Vora A, Husain MM. Defining treatment-resistant depression: a comprehensive review of the literature. Ann Clin Psychiatry. 2014;26:222\u201332.","journal-title":"Ann Clin Psychiatry"},{"key":"3649_CR8","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1038\/sj.mp.4001015","volume":"7","author":"A Frazer","year":"2002","unstructured":"Frazer A, Benmansour S. Delayed pharmacological effects of antidepressants. Mol Psychiatry. 2002;7:S23\u2013S28.","journal-title":"Mol Psychiatry"},{"key":"3649_CR9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4088\/JCP.v61n1002","volume":"61","author":"AJ Gelenberg","year":"2000","unstructured":"Gelenberg AJ, Chesen CL. How fast are antidepressants? J Clin Psychiatry. 2000;61:712\u201321.","journal-title":"J Clin Psychiatry"},{"key":"3649_CR10","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.3390\/ijms21218220","volume":"21","author":"J Kornhuber","year":"2020","unstructured":"Kornhuber J, Zoicas I. Neuropeptide Y as alternative pharmacotherapy for antidepressant-resistant social fear. IJMS. 2020;21:8220.","journal-title":"IJMS"},{"key":"3649_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nm.3214","volume":"19","author":"E Gulbins","year":"2013","unstructured":"Gulbins E, Palmada M, Reichel M, L\u00fcth A, B\u00f6hmer C, Amato D, et al. Acid sphingomyelinase\u2013ceramide system mediates effects of antidepressant drugs. Nat Med. 2013;19:934\u20138.","journal-title":"Nat Med"},{"key":"3649_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tips.2014.04.003","volume":"35","author":"J Kornhuber","year":"2014","unstructured":"Kornhuber J, M\u00fcller CP, Becker KA, Reichel M, Gulbins E. The ceramide system as a novel antidepressant target. Trends Pharmacol Sci. 2014;35:293\u2013304.","journal-title":"Trends Pharmacol Sci"},{"key":"3649_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.bbalip.2014.12.014","volume":"1851","author":"CP M\u00fcller","year":"2015","unstructured":"M\u00fcller CP, Reichel M, M\u00fchle C, Rhein C, Gulbins E, Kornhuber J. Brain membrane lipids in major depression and anxiety disorders. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2015;1851:1052\u201365.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"3649_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neubiorev.2016.06.002","volume":"76","author":"M Schneider","year":"2017","unstructured":"Schneider M, Levant B, Reichel M, Gulbins E, Kornhuber J, M\u00fcller CP. Lipids in psychiatric disorders and preventive medicine. Neurosci & Biobehav Rev. 2017;76:336\u201362.","journal-title":"Neurosci & Biobehav Rev"},{"key":"3649_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0024-3205(86)90083-4","volume":"38","author":"S Albouz","year":"1986","unstructured":"Albouz S, Le Saux F, Wenger D, Hauw JJ, Baumann N. Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines. Life Sci. 1986;38:357\u201363.","journal-title":"Life Sci"},{"key":"3649_CR16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00702-005-0374-5","volume":"112","author":"J Kornhuber","year":"2005","unstructured":"Kornhuber J, Medlin A, Bleich S, Jendrossek V, Henkel AW, Wiltfang J, et al. High activity of acid sphingomyelinase in major depression. J Neural Transm. 2005;112:1583\u201390.","journal-title":"J Neural Transm"},{"key":"3649_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/jm070524a","volume":"51","author":"J Kornhuber","year":"2008","unstructured":"Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, et al. Identification of new functional inhibitors of acid sphingomyelinase using a Structure\u2212Property\u2212Activity relation model. J Med Chem. 2008;51:219\u201337.","journal-title":"J Med Chem"},{"key":"3649_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000315101","volume":"26","author":"J Kornhuber","year":"2010","unstructured":"Kornhuber J, Tripal P, Reichel M, M\u00fchle C, Rhein C, Muehlbacher M, et al. Functional inhibitors of acid sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem. 2010;26:9\u201320.","journal-title":"Cell Physiol Biochem"},{"key":"3649_CR19","doi-asserted-by":"publisher","first-page":"e23852","DOI":"10.1371\/journal.pone.0023852","volume":"6","author":"J Kornhuber","year":"2011","unstructured":"Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, et al. Identification of novel functional inhibitors of acid sphingomyelinase. PLoS ONE. 2011;6:e23852.","journal-title":"PLoS ONE"},{"key":"3649_CR20","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1038\/s41380-021-01254-3","volume":"26","author":"N Hoertel","year":"2021","unstructured":"Hoertel N, S\u00e1nchez-Rico M, Cougoule C, Gulbins E, Kornhuber J, Carpinteiro A, et al. Repurposing antidepressants inhibiting the sphingomyelinase acid\/ceramide system against COVID-19: current evidence and potential mechanisms. Mol Psychiatry. 2021;26:7098\u20139.","journal-title":"Mol Psychiatry"},{"key":"3649_CR21","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","volume":"26","author":"N Hoertel","year":"2021","unstructured":"Hoertel N, S\u00e1nchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021;26:5199\u2013212.","journal-title":"Mol Psychiatry"},{"key":"3649_CR22","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/cpt.2317","volume":"110","author":"N Hoertel","year":"2021","unstructured":"Hoertel N, S\u00e1nchez\u2010Rico M, Gulbins E, Kornhuber J, Carpinteiro A, Lenze EJ, et al. Association between FIASMAs and reduced risk of intubation or death in individuals hospitalized for severe COVID\u201019: an observational multicenter study. Clin Pharma Ther. 2021;110:1498\u2013511.","journal-title":"Clin Pharma Ther"},{"key":"3649_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100701","volume":"296","author":"A Carpinteiro","year":"2021","unstructured":"Carpinteiro A, Gripp B, Hoffmann M, P\u00f6hlmann S, Hoertel N, Edwards MJ, et al. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells. J Biol Chem. 2021;296:100701.","journal-title":"J Biol Chem"},{"key":"3649_CR24","doi-asserted-by":"publisher","first-page":"e2136510","DOI":"10.1001\/jamanetworkopen.2021.36510","volume":"4","author":"N Hoertel","year":"2021","unstructured":"Hoertel N. Do the selective serotonin reuptake inhibitor antidepressants fluoxetine and fluvoxamine reduce mortality among patients with COVID-19? JAMA Netw Open. 2021;4:e2136510.","journal-title":"JAMA Netw Open"},{"key":"3649_CR25","doi-asserted-by":"publisher","first-page":"103036","DOI":"10.1016\/j.eclinm.2024.103036","volume":"80","author":"P Jittamala","year":"2025","unstructured":"Jittamala P, Boyd S, Schilling WHK, Watson JA, Ngamprasertchai T, Siripoon T, et al. Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV). eClinicalMedicine. 2025;80:103036.","journal-title":"eClinicalMedicine"},{"key":"3649_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41380-021-01309-5","volume":"27","author":"J Kornhuber","year":"2022","unstructured":"Kornhuber J, Hoertel N, Gulbins E. The acid sphingomyelinase\/ceramide system in COVID-19. Mol Psychiatry. 2022;27:307\u201314.","journal-title":"Mol Psychiatry"},{"key":"3649_CR27","doi-asserted-by":"publisher","first-page":"13623","DOI":"10.3390\/ijms232113623","volume":"23","author":"D P\u00e9ricat","year":"2022","unstructured":"P\u00e9ricat D, Leon-Icaza SA, Sanchez Rico M, M\u00fchle C, Zoicas I, Schumacher F, et al. Antiviral and anti-inflammatory activities of fluoxetine in a SARS-CoV-2 infection mouse model. IJMS. 2022;23:13623.","journal-title":"IJMS"},{"key":"3649_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/v16040545","volume":"16","author":"L Th\u00fcmmler","year":"2024","unstructured":"Th\u00fcmmler L, Beckmann N, Sehl C, Soddemann M, Bra\u00df P, Bormann M, et al. Fluoxetine and sertraline potently neutralize the replication of distinct SARS-CoV-2 variants. Viruses. 2024;16:545.","journal-title":"Viruses"},{"key":"3649_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102517","volume":"70","author":"DL Wannigama","year":"2024","unstructured":"Wannigama DL, Hurst C, Phattharapornjaroen P, Hongsing P, Sirichumroonwit N, Chanpiwat K, et al. Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial. eClinicalMedicine. 2024;70:102517.","journal-title":"eClinicalMedicine"},{"key":"3649_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02109-3","volume":"12","author":"BA Fritz","year":"2022","unstructured":"Fritz BA, Hoertel N, Lenze EJ, Jalali F, Reiersen AM. Association between antidepressant use and ED or hospital visits in outpatients with SARS-CoV-2. Transl Psychiatry. 2022;12:341.","journal-title":"Transl Psychiatry"},{"key":"3649_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/ph16081107","volume":"16","author":"N Hoertel","year":"2023","unstructured":"Hoertel N, Rezaei K, S\u00e1nchez-Rico M, Delgado-\u00c1lvarez A, Kornhuber J, Gulbins E, et al. Medications modulating the acid sphingomyelinase\/ceramide system and 28-day mortality among patients with SARS-CoV-2: An observational study. Pharmaceuticals. 2023;16:1107.","journal-title":"Pharmaceuticals"},{"key":"3649_CR32","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41380-021-01393-7","volume":"27","author":"N Hoertel","year":"2022","unstructured":"Hoertel N, S\u00e1nchez-Rico M, Herrera-Morueco JJ, De La Muela P, Gulbins E, Kornhuber J, et al. Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients. Mol Psychiatry. 2022;27:1278\u201380.","journal-title":"Mol Psychiatry"},{"key":"3649_CR33","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.3390\/jcm11195882","volume":"11","author":"N Hoertel","year":"2022","unstructured":"Hoertel N, S\u00e1nchez-Rico M, Kornhuber J, Gulbins E, Reiersen AM, Lenze EJ, et al. Antidepressant use and its association with 28-Day mortality in inpatients with SARS-CoV-2: support for the FIASMA model against COVID-19. JCM. 2022;11:5882.","journal-title":"JCM"},{"key":"3649_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64260-9","volume":"14","author":"MI Prasanth","year":"2024","unstructured":"Prasanth MI, Wannigama DL, Reiersen AM, Thitilertdecha P, Prasansuklab A, Tencomnao T, et al. A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications. Sci Rep. 2024;14:13462.","journal-title":"Sci Rep"},{"key":"3649_CR35","first-page":"1382","volume":"5","author":"HP Loomer","year":"1957","unstructured":"Loomer HP, Saunders JC, Kline NS. Iproniazid, an amine inhibitor, as an example of a psychic energizer. Congress Rec. 1957;5:1382\u201390.","journal-title":"Congress Rec"},{"key":"3649_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00406-009-0061-x","volume":"259","author":"J Kornhuber","year":"2009","unstructured":"Kornhuber J, Reichel M, Tripal P, Groemer TW, Henkel AW, M\u00fchle C, et al. The role of ceramide in major depressive disorder. Eur Arch Psychiatry Clin Neurosci. 2009;259:199\u2013204.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3649_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1213011","volume":"14","author":"AR Van Der Heijden","year":"2023","unstructured":"Van Der Heijden AR, Houben T. Lipids in major depressive disorder: new kids on the block or old friends revisited? Front Psychiatry. 2023;14:1213011.","journal-title":"Front Psychiatry"},{"key":"3649_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018;19:175\u201391.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3649_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1515\/hsz-2018-0237","volume":"399","author":"G Van Echten-Deckert","year":"2018","unstructured":"Van Echten-Deckert G, Alam S. Sphingolipid metabolism \u2013 an ambiguous regulator of autophagy in the brain. Biol Chem. 2018;399:837\u201350.","journal-title":"Biol Chem"},{"key":"3649_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.metabol.2019.04.002","volume":"95","author":"N Brunkhorst-Kanaan","year":"2019","unstructured":"Brunkhorst-Kanaan N, Klatt-Schreiner K, Hackel J, Schr\u00f6ter K, Trautmann S, Hahnefeld L, et al. Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder. Metabolism. 2019;95:65\u201376.","journal-title":"Metabolism"},{"key":"3649_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1176\/jnp.23.2.jnp215","volume":"23","author":"P Gracia-Garcia","year":"2011","unstructured":"Gracia-Garcia P, Rao V, Haughey NJ, Ratnam Banduru VV, Smith G, Rosenberg PB, et al. Elevated plasma ceramides in depression. JNP. 2011;23:215\u20138.","journal-title":"JNP"},{"key":"3649_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jad.2017.02.008","volume":"213","author":"A Dinoff","year":"2017","unstructured":"Dinoff A, Herrmann N, Lanct\u00f4t KL. Ceramides and depression: A systematic review. J Affect Disord. 2017;213:35\u201343.","journal-title":"J Affect Disord"},{"key":"3649_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/jnc.13145","volume":"134","author":"E Gulbins","year":"2015","unstructured":"Gulbins E, Walter S, Becker KA, Halmer R, Liu Y, Reichel M, et al. A central role for the acid sphingomyelinase\/ceramide system in neurogenesis and major depression. J Neurochem. 2015;134:183\u201392.","journal-title":"J Neurochem"},{"key":"3649_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/070674371405901206","volume":"59","author":"RW Lam","year":"2014","unstructured":"Lam RW, Kennedy SH, McIntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59:649\u201354.","journal-title":"Can J Psychiatry"},{"key":"3649_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/da.22063","volume":"30","author":"RS McIntyre","year":"2013","unstructured":"McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30:515\u201327.","journal-title":"Depress Anxiety"},{"key":"3649_CR46","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1017\/S0033291713002535","volume":"44","author":"PL Rock","year":"2014","unstructured":"Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029\u201340.","journal-title":"Psychol Med"},{"key":"3649_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jad.2013.09.012","volume":"152-154","author":"MH Trivedi","year":"2014","unstructured":"Trivedi MH, Greer TL. Cognitive dysfunction in unipolar depression: Implications for treatment. J Affect Disord. 2014;152-154:19\u201327.","journal-title":"J Affect Disord"},{"key":"3649_CR48","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1017\/S0033291710001911","volume":"41","author":"HJ Conradi","year":"2011","unstructured":"Conradi HJ, Ormel J, De Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41:1165\u201374.","journal-title":"Psychol Med"},{"key":"3649_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.psychres.2005.11.011","volume":"145","author":"J Jaeger","year":"2006","unstructured":"Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145:39\u201348.","journal-title":"Psychiatry Res"},{"key":"3649_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","volume":"70","author":"C Mencarelli","year":"2013","unstructured":"Mencarelli C, Martinez\u2013Martinez P. Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci. 2013;70:181\u2013203.","journal-title":"Cell Mol Life Sci"},{"key":"3649_CR51","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","volume":"6","author":"JS O\u2019Brien","year":"1965","unstructured":"O\u2019Brien JS, Sampson EL. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res. 1965;6:537\u201344.","journal-title":"J Lipid Res"},{"key":"3649_CR52","doi-asserted-by":"publisher","first-page":"170069","DOI":"10.1098\/rsob.170069","volume":"7","author":"ASB Olsen","year":"2017","unstructured":"Olsen ASB, F\u00e6rgeman NJ. Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol. 2017;7:170069.","journal-title":"Open Biol"},{"key":"3649_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/sj.embor.7400208","volume":"5","author":"AH Futerman","year":"2004","unstructured":"Futerman AH, Hannun YA. The complex life of simple sphingolipids. EMBO Rep. 2004;5:777\u201382.","journal-title":"EMBO Rep"},{"key":"3649_CR54","doi-asserted-by":"publisher","first-page":"25843","DOI":"10.1074\/jbc.R200009200","volume":"277","author":"AH Merrill","year":"2002","unstructured":"Merrill AH. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem. 2002;277:25843\u20136.","journal-title":"J Biol Chem"},{"key":"3649_CR55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9:139\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3649_CR56","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/jnc.15759","volume":"164","author":"S Bernal\u2010Vega","year":"2023","unstructured":"Bernal\u2010Vega S, Garc\u00eda\u2010Ju\u00e1rez M, Camacho\u2010Morales A. Contribution of ceramides metabolism in psychiatric disorders. J Neurochem. 2023;164:708\u201324.","journal-title":"J Neurochem"},{"key":"3649_CR57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","volume":"4","author":"S Spiegel","year":"2003","unstructured":"Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4:397\u2013407.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3649_CR58","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/381800a0","volume":"381","author":"O Cuvillier","year":"1996","unstructured":"Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 1996;381:800\u20133.","journal-title":"Nature"},{"key":"3649_CR59","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.bbamem.2006.08.007","volume":"1758","author":"NC Hait","year":"2006","unstructured":"Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2006;1758:2016\u201326.","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"3649_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.advenzreg.2009.10.024","volume":"50","author":"M Serra","year":"2010","unstructured":"Serra M, Saba JD. Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. Adv Enzyme Regul. 2010;50:349\u201362.","journal-title":"Adv Enzyme Regul"},{"key":"3649_CR61","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/jnc.13589","volume":"137","author":"S Sonnino","year":"2016","unstructured":"Sonnino S, Prinetti A. The role of sphingolipids in neuronal plasticity of the brain. J Neurochem. 2016;137:485\u20138.","journal-title":"J Neurochem"},{"key":"3649_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5650\/jos.60.537","volume":"60","author":"RK Yu","year":"2011","unstructured":"Yu RK, Tsai Y-T, Ariga T, Yanagisawa M. Structures, biosynthesis, and functions of gangliosides-an overview. J Oleo Sci. 2011;60:537\u201344.","journal-title":"J Oleo Sci"},{"key":"3649_CR63","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1515\/hsz-2017-0148","volume":"398","author":"Y Chen","year":"2017","unstructured":"Chen Y, Cao Y. The sphingomyelin synthase family: proteins, diseases, and inhibitors. Biol Chem. 2017;398:1319\u201325.","journal-title":"Biol Chem"},{"key":"3649_CR64","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0014-5793(02)03482-8","volume":"531","author":"FM Go\u00f1i","year":"2002","unstructured":"Go\u00f1i FM, Alonso A. Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 2002;531:38\u201346.","journal-title":"FEBS Lett"},{"key":"3649_CR65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1388-1981(03)00059-3","volume":"1632","author":"K Hanada","year":"2003","unstructured":"Hanada K. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2003;1632:16\u201330.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"3649_CR66","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","volume":"20","author":"K Kitatani","year":"2008","unstructured":"Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008;20:1010\u20138.","journal-title":"Cell Signal"},{"key":"3649_CR67","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/iub.319","volume":"62","author":"M Levy","year":"2010","unstructured":"Levy M, Futerman AH. Mammalian ceramide synthases. IUBMB Life. 2010;62:347\u201356.","journal-title":"IUBMB Life"},{"key":"3649_CR68","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","volume":"1781","author":"C Mao","year":"2008","unstructured":"Mao C, Obeid LM. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2008;1781:424\u201334.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"3649_CR69","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1046\/j.1471-4159.1998.71062528.x","volume":"71","author":"M Martinez","year":"1998","unstructured":"Martinez M, Mougan I. Fatty acid composition of human brain phospholipids during normal development. J Neurochem. 1998;71:2528\u201333.","journal-title":"J Neurochem"},{"key":"3649_CR70","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","volume":"584","author":"E Posse De Chaves","year":"2010","unstructured":"Posse De Chaves E, Sipione S. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 2010;584:1748\u201359.","journal-title":"FEBS Lett"},{"key":"3649_CR71","doi-asserted-by":"publisher","first-page":"25512","DOI":"10.1074\/jbc.M202947200","volume":"277","author":"P Ternes","year":"2002","unstructured":"Ternes P, Franke S, Z\u00e4hringer U, Sperling P, Heinz E. Identification and characterization of a sphingolipid \u03944-Desaturase family. J Biol Chem. 2002;277:25512\u20138.","journal-title":"J Biol Chem"},{"key":"3649_CR72","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mp.2015.14","volume":"21","author":"TG Oliveira","year":"2016","unstructured":"Oliveira TG, Chan RB, Bravo FV, Miranda A, Silva RR, Zhou B, et al. The impact of chronic stress on the rat brain lipidome. Mol Psychiatry. 2016;21:80\u201388.","journal-title":"Mol Psychiatry"},{"key":"3649_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0478-6","volume":"9","author":"AM Miranda","year":"2019","unstructured":"Miranda AM, Bravo FV, Chan RB, Sousa N, Di Paolo G, Oliveira TG. Differential lipid composition and regulation along the hippocampal longitudinal axis. Transl Psychiatry. 2019;9:144.","journal-title":"Transl Psychiatry"},{"key":"3649_CR74","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fpsyt.2018.00496","volume":"9","author":"M Reichel","year":"2018","unstructured":"Reichel M, Rhein C, Hofmann LM, Monti J, Japtok L, Langgartner D, et al. Chronic psychosocial stress in mice is associated with increased acid sphingomyelinase activity in liver and serum and with hepatic C16:0-ceramide accumulation. Front Psychiatry. 2018;9:496.","journal-title":"Front Psychiatry"},{"key":"3649_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102185","volume":"298","author":"F Schumacher","year":"2022","unstructured":"Schumacher F, Edwards MJ, M\u00fchle C, Carpinteiro A, Wilson GC, Wilker B, et al. Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in mice. J Biol Chem. 2022;298:102185.","journal-title":"J Biol Chem"},{"key":"3649_CR76","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1021\/acs.jmedchem.9b00739","volume":"63","author":"K Yang","year":"2020","unstructured":"Yang K, Yu J, Nong K, Wang Y, Niu A, Chen W, et al. Discovery of potent, selective, and direct acid sphingomyelinase inhibitors with antidepressant activity. J Med Chem. 2020;63:961\u201374.","journal-title":"J Med Chem"},{"key":"3649_CR77","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1177\/0269881120915412","volume":"34","author":"E Jaddoa","year":"2020","unstructured":"Jaddoa E, Masania J, Masiero E, Sgamma T, Arroo R, Sillence D, et al. Effect of antidepressant drugs on the brain sphingolipid system. J Psychopharmacol. 2020;34:716\u201325.","journal-title":"J Psychopharmacol"},{"key":"3649_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12847","volume":"25","author":"I Zoicas","year":"2020","unstructured":"Zoicas I, Huber SE, Kalinichenko LS, Gulbins E, M\u00fcller CP, Kornhuber J. Ceramides affect alcohol consumption and depressive\u2010like and anxiety\u2010like behavior in a brain region\u2010 and ceramide species\u2010specific way in male mice. Addict Biol. 2020;25:e12847.","journal-title":"Addict Biol"},{"key":"3649_CR79","doi-asserted-by":"publisher","first-page":"fasebj.2022.36.","DOI":"10.1096\/fasebj.2022.36.S1.L7410","volume":"36","author":"W Fonseca\u2010Ferrer","year":"2022","unstructured":"Fonseca\u2010Ferrer W, Su\u00e1rez\u2010Gomez C, Sambolin\u2010Escobales L, Santos\u2010Avil\u00e9s K, Col\u00f3n\u2010Romero M, Hern\u00e1ndez\u2010L\u00f3pez A, et al. Infusion of C20 ceramide induces depressive\u2010like behavior, increases microglia but not astrocyte expression. FASEB J. 2022;36:fasebj.2022.36.S1.L7410.","journal-title":"FASEB J"},{"key":"3649_CR80","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.1038\/s41380-021-01304-w","volume":"26","author":"LS Kalinichenko","year":"2021","unstructured":"Kalinichenko LS, M\u00fchle C, Jia T, Anderheiden F, Datz M, Eberle A-L, et al. Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects. Mol Psychiatry. 2021;26:7403\u201316.","journal-title":"Mol Psychiatry"},{"key":"3649_CR81","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/cercor\/bhac106","volume":"33","author":"LS Kalinichenko","year":"2023","unstructured":"Kalinichenko LS, M\u00fchle C, Jia T, Anderheiden F, Datz M, Eberle A-L, et al. Adult alcohol drinking and emotional tone are mediated by neutral sphingomyelinase during development in males. Cereb Cortex. 2023;33:844\u201364.","journal-title":"Cereb Cortex"},{"key":"3649_CR82","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1038\/s41380-018-0090-9","volume":"23","author":"A Gulbins","year":"2018","unstructured":"Gulbins A, Schumacher F, Becker KA, Wilker B, Soddemann M, Boldrin F, et al. Antidepressants act by inducing autophagy controlled by sphingomyelin\u2013ceramide. Mol Psychiatry. 2018;23:2324\u201346.","journal-title":"Mol Psychiatry"},{"key":"3649_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.836","volume":"7","author":"A Dinoff","year":"2017","unstructured":"Dinoff A, Saleem M, Herrmann N, Mielke MM, Oh PI, Venkata SLV, et al. Plasma sphingolipids and depressive symptoms in coronary artery disease. Brain Behav. 2017;7:e00836.","journal-title":"Brain Behav"},{"key":"3649_CR84","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1523\/JNEUROSCI.5713-07.2008","volume":"28","author":"RJ Donati","year":"2008","unstructured":"Donati RJ, Dwivedi Y, Roberts RC, Conley RR, Pandey GN, Rasenick MM. Postmortem brain tissue of depressed suicides reveals increased gs\u03b1 localization in lipid raft domains where it is less likely to activate adenylyl cyclase. J Neurosci. 2008;28:3042\u201350.","journal-title":"J Neurosci"},{"key":"3649_CR85","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/jcm8060846","volume":"8","author":"C M\u00fchle","year":"2019","unstructured":"M\u00fchle C, Wagner C, F\u00e4rber K, Richter-Schmidinger T, Gulbins E, Lenz B, et al. Secretory acid sphingomyelinase in the serum of medicated patients predicts the prospective course of depression. JCM. 2019;8:846.","journal-title":"JCM"},{"key":"3649_CR86","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00109-022-02250-y","volume":"100","author":"F Schumacher","year":"2022","unstructured":"Schumacher F, Carpinteiro A, Edwards MJ, Wilson GC, Keitsch S, Soddemann M, et al. Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma. J Mol Med. 2022;100:1493\u2013508.","journal-title":"J Mol Med"},{"key":"3649_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109948","volume":"253","author":"I Wank","year":"2024","unstructured":"Wank I, Mittmann C, Kreitz S, Chestnykh D, M\u00fchle C, Kornhuber J, et al. Neutral sphingomyelinase controls acute and chronic alcohol effects on brain activity. Neuropharmacology. 2024;253:109948.","journal-title":"Neuropharmacology"},{"key":"3649_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01182-w","volume":"11","author":"RJT Mocking","year":"2021","unstructured":"Mocking RJT, Naviaux JC, Li K, Wang L, Monk JM, Bright AT, et al. Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence. Transl Psychiatry. 2021;11:37.","journal-title":"Transl Psychiatry"},{"key":"3649_CR89","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.steroids.2010.01.020","volume":"75","author":"NC Lucki","year":"2010","unstructured":"Lucki NC, Sewer MB. The interplay between bioactive sphingolipids and steroid hormones. Steroids. 2010;75:390\u20139.","journal-title":"Steroids"},{"key":"3649_CR90","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/sj.npp.1300358","volume":"29","author":"RA Chambers","year":"2004","unstructured":"Chambers RA, Potenza MN, Hoffman RE, Miranker W. Simulated apoptosis\/neurogenesis regulates learning and memory capabilities of adaptive neural networks. Neuropsychopharmacol. 2004;29:747\u201358.","journal-title":"Neuropsychopharmacol"},{"key":"3649_CR91","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0006-3223(99)00177-8","volume":"46","author":"RS Duman","year":"1999","unstructured":"Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry. 1999;46:1181\u201391.","journal-title":"Biol Psychiatry"},{"key":"3649_CR92","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrn2822","volume":"11","author":"W Deng","year":"2010","unstructured":"Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci. 2010;11:339\u201350.","journal-title":"Nat Rev Neurosci"},{"key":"3649_CR93","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1161\/01.CIR.0000035650.05921.50","volume":"106","author":"H Li","year":"2002","unstructured":"Li H, Junk P, Huwiler A, Burkhardt C, Wallerath T, Pfeilschifter J, et al. Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation. 2002;106:2250\u20136.","journal-title":"Circulation"},{"key":"3649_CR94","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1089\/neu.2019.6436","volume":"37","author":"GM Niziolek","year":"2020","unstructured":"Niziolek GM, Boudreau RM, Baker J, Friend LA, Makley AT, Edwards MJ, et al. Acid sphingomyelinase inhibition mitigates histopathological and behavioral changes in a murine model of traumatic brain injury. J Neurotrauma. 2020;37:1902\u20139.","journal-title":"J Neurotrauma"},{"key":"3649_CR95","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.0953-816x.2001.01634.x","volume":"14","author":"AJ MacLennan","year":"2001","unstructured":"MacLennan AJ, Carney PR, Zhu WJ, Chaves AH, Garcia J, Grimes JR, et al. An essential role for the H218\/AGR16\/Edg\u20105\/LPB2 sphingosine 1\u2010phosphate receptor in neuronal excitability. Eur J of Neurosci. 2001;14:203\u20139.","journal-title":"Eur J of Neurosci"},{"key":"3649_CR96","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","volume":"25","author":"K Mizugishi","year":"2005","unstructured":"Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol. 2005;25:11113\u201321.","journal-title":"Mol Cell Biol"},{"key":"3649_CR97","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn2059","volume":"8","author":"JA Allen","year":"2007","unstructured":"Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007;8:128\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"3649_CR98","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1021\/acschemneuro.3c00823","volume":"15","author":"LS Kalinichenko","year":"2024","unstructured":"Kalinichenko LS, Kornhuber J, Sinning S, Haase J, M\u00fcller CP. Serotonin signaling through lipid membranes. ACS Chem Neurosci. 2024;15:1298\u2013320.","journal-title":"ACS Chem Neurosci"},{"key":"3649_CR99","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bbamem.2016.10.016","volume":"1859","author":"M Jafurulla","year":"2017","unstructured":"Jafurulla M, Bandari S, Pucadyil TJ, Chattopadhyay A. Sphingolipids modulate the function of human serotonin 1A receptors: Insights from sphingolipid-deficient cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2017;1859:598\u2013604.","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"3649_CR100","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1021\/bi1001536","volume":"49","author":"YD Paila","year":"2010","unstructured":"Paila YD, Ganguly S, Chattopadhyay A. Metabolic depletion of sphingolipids impairs ligand binding and signaling of human Serotonin1A receptors. Biochemistry. 2010;49:2389\u201397.","journal-title":"Biochemistry"},{"key":"3649_CR101","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.bbamem.2008.07.007","volume":"1778","author":"M Jafurulla","year":"2008","unstructured":"Jafurulla M, Pucadyil TJ, Chattopadhyay A. Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2008;1778:2022\u20135.","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"3649_CR102","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-016-1658-6","volume":"133","author":"CP M\u00fcller","year":"2017","unstructured":"M\u00fcller CP, Kalinichenko LS, Tiesel J, Witt M, St\u00f6ckl T, Sprenger E, et al. Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasis. Acta Neuropathol. 2017;133:463\u201383.","journal-title":"Acta Neuropathol"},{"key":"3649_CR103","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.brainresbull.2019.01.026","volume":"146","author":"LS Kalinichenko","year":"2019","unstructured":"Kalinichenko LS, Hammad L, Reichel M, Kohl Z, Gulbins E, Kornhuber J, et al. Acid sphingomyelinase controls dopamine activity and responses to appetitive stimuli in mice. Brain Res Bull. 2019;146:310\u20139.","journal-title":"Brain Res Bull"},{"key":"3649_CR104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-2999(02)02727-9","volume":"458","author":"EL Riddle","year":"2003","unstructured":"Riddle EL, Rau KS, Topham MK, Hanson GR, Fleckenstein AE. Ceramide-induced alterations in dopamine transporter function. Eur J Pharmacol. 2003;458:31\u201336.","journal-title":"Eur J Pharmacol"},{"key":"3649_CR105","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1471-4159.2005.03403.x","volume":"95","author":"HJ Jeon","year":"2005","unstructured":"Jeon HJ, Lee DH, Kang MS, Lee M, Jung KM, Jung SY, et al. Dopamine release in PC12 cells is mediated by Ca2+ \u2010dependent production of ceramide via sphingomyelin pathway. J Neurochem. 2005;95:811\u201320.","journal-title":"J Neurochem"},{"key":"3649_CR106","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"3649_CR107","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"3649_CR108","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446\u201357.","journal-title":"Biol Psychiatry"},{"key":"3649_CR109","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171\u201386.","journal-title":"Psychosom Med"},{"key":"3649_CR110","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00702-020-02288-7","volume":"128","author":"C Von Zimmermann","year":"2021","unstructured":"Von Zimmermann C, B\u00f6hm L, Richter-Schmidinger T, Kornhuber J, Lenz B, M\u00fchle C. Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity. J Neural Transm. 2021;128:95\u2013104.","journal-title":"J Neural Transm"},{"key":"3649_CR111","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","volume":"42","author":"SG Torres-Platas","year":"2014","unstructured":"Torres-Platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun. 2014;42:50\u20139.","journal-title":"Brain Behav Immun"},{"key":"3649_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5378284","volume":"2018","author":"S Gr\u00f6sch","year":"2018","unstructured":"Gr\u00f6sch S, Alessenko AV, Albi E. The many facets of sphingolipids in the specific phases of acute inflammatory response. Mediators Inflamm. 2018;2018:1\u201312.","journal-title":"Mediators Inflamm"},{"key":"3649_CR113","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1038\/sj.onc.1207146","volume":"22","author":"E Gulbins","year":"2003","unstructured":"Gulbins E, Kolesnick R. Raft ceramide in molecular medicine. Oncogene. 2003;22:7070\u20137.","journal-title":"Oncogene"},{"key":"3649_CR114","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.neurobiolaging.2010.11.002","volume":"33","author":"X Wu","year":"2012","unstructured":"Wu X, Lu Y, Dong Y, Zhang G, Zhang Y, Xu Z, et al. The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-\u03b1, IL-6, and IL-1\u03b2. Neurobiol Aging. 2012;33:1364\u201378.","journal-title":"Neurobiol Aging"},{"key":"3649_CR115","doi-asserted-by":"publisher","first-page":"11369","DOI":"10.1074\/jbc.272.17.11369","volume":"272","author":"C Garc\u00eda-Ruiz","year":"1997","unstructured":"Garc\u00eda-Ruiz C, Colell A, Mar\u00ed M, Morales A, Fern\u00e1ndez-Checa JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. J Biol Chem. 1997;272:11369\u201377.","journal-title":"J Biol Chem"},{"key":"3649_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.899627","volume":"16","author":"L Sambol\u00edn-Escobales","year":"2022","unstructured":"Sambol\u00edn-Escobales L, Feliciano-Qui\u00f1ones A, Tirado-Castro L, Su\u00e1rez C, Pacheco-Cruz D, Irizarry-M\u00e9ndez N, et al. Infusion of C20:0 ceramide into ventral hippocampus triggers anhedonia-like behavior in female and male rats. Front Behav Neurosci. 2022;16:899627.","journal-title":"Front Behav Neurosci"},{"key":"3649_CR117","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.psyneuen.2014.09.025","volume":"51","author":"CN Black","year":"2015","unstructured":"Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BWJH. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology. 2015;51:164\u201375.","journal-title":"Psychoneuroendocrinology"},{"key":"3649_CR118","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1159\/000341460","volume":"30","author":"X Li","year":"2012","unstructured":"Li X, Gulbins E, Zhang Y. Oxidative stress triggers Ca2+ -dependent lysosome trafficking and activation of acid sphingomyelinase. Cell Physiol Biochem. 2012;30:815\u201326.","journal-title":"Cell Physiol Biochem"},{"key":"3649_CR119","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.freeradbiomed.2006.01.035","volume":"40","author":"J-S Won","year":"2006","unstructured":"Won J-S, Singh I. Sphingolipid signaling and redox regulation. Free Radic Biol Med. 2006;40:1875\u201388.","journal-title":"Free Radic Biol Med"},{"key":"3649_CR120","first-page":"347","volume":"2","author":"SA Novgorodov","year":"2011","unstructured":"Novgorodov SA, Gudz TI. Ceramide and mitochondria in ischemic brain injury. Int J Biochem Mol Biol. 2011;2:347\u201361.","journal-title":"Int J Biochem Mol Biol"},{"key":"3649_CR121","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/187152012800228661","volume":"12","author":"TD Mullen","year":"2012","unstructured":"Mullen TD, Obeid LM. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. ACAMC. 2012;12:340\u201363.","journal-title":"ACAMC"},{"key":"3649_CR122","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/cercor\/bhaa298","volume":"31","author":"LS Kalinichenko","year":"2021","unstructured":"Kalinichenko LS, Abdel-Hafiz L, Wang A-L, M\u00fchle C, R\u00f6sel N, Schumacher F, et al. Neutral sphingomyelinase is an affective valence-dependent regulator of learning and memory. Cereb Cortex. 2021;31:1316\u201333.","journal-title":"Cereb Cortex"},{"key":"3649_CR123","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1471-4159.2004.03009.x","volume":"93","author":"S Besshoh","year":"2005","unstructured":"Besshoh S, Bawa D, Teves L, Wallace MC, Gurd JW. Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post\u2010synaptic densities following transient global ischemia in the rat brain. J Neurochem. 2005;93:186\u201394.","journal-title":"J Neurochem"},{"key":"3649_CR124","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1471-4159.2009.06038.x","volume":"109","author":"D Wheeler","year":"2009","unstructured":"Wheeler D, Knapp E, Bandaru VVR, Wang Y, Knorr D, Poirier C, et al. Tumor necrosis factor\u2010\u03b1\u2010induced neutral sphingomyelinase\u20102 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem. 2009;109:1237\u201349.","journal-title":"J Neurochem"},{"key":"3649_CR125","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1002\/jnr.22438","volume":"88","author":"N Tabatadze","year":"2010","unstructured":"Tabatadze N, Savonenko A, Song H, Bandaru VVR, Chu M, Haughey NJ. Inhibition of neutral sphingomyelinase\u20102 perturbs brain sphingolipid balance and spatial memory in mice. J Neurosci Res. 2010;88:2940\u201351.","journal-title":"J Neurosci Res"},{"key":"3649_CR126","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/jnc.13537","volume":"137","author":"JP Huston","year":"2016","unstructured":"Huston JP, Kornhuber J, M\u00fchle C, Japtok L, Komorowski M, Mattern C, et al. A sphingolipid mechanism for behavioral extinction. J Neurochem. 2016;137:589\u2013603.","journal-title":"J Neurochem"},{"key":"3649_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2022.101162","volume":"86","author":"LS Kalinichenko","year":"2022","unstructured":"Kalinichenko LS, Gulbins E, Kornhuber J, M\u00fcller CP. Sphingolipid control of cognitive functions in health and disease. Prog Lipid Res. 2022;86:101162.","journal-title":"Prog Lipid Res"},{"key":"3649_CR128","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s43440-020-00159-2","volume":"73","author":"LS Kalinichenko","year":"2021","unstructured":"Kalinichenko LS, Wang A-L, M\u00fchle C, Abdel-Hafiz L, Gulbins E, Kornhuber J, et al. Neutral ceramidase is a marker for cognitive performance in rats and monkeys. Pharmacol Rep. 2021;73:73\u201384.","journal-title":"Pharmacol Rep"},{"key":"3649_CR129","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.neuint.2010.09.013","volume":"57","author":"HC K\u00f6feler","year":"2010","unstructured":"K\u00f6feler HC, Tiboldi A, Hoeger H, Lubec G. Hippocampal lipids linked to spatial memory in the C57bl\/6j mouse. Neurochem Int. 2010;57:935\u20139.","journal-title":"Neurochem Int"},{"key":"3649_CR130","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35:676\u201392.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3649_CR131","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","volume":"161","author":"P Videbech","year":"2004","unstructured":"Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. AJP. 2004;161:1957\u201366.","journal-title":"AJP"},{"key":"3649_CR132","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","volume":"25","author":"R Yirmiya","year":"2011","unstructured":"Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011;25:181\u2013213.","journal-title":"Brain Behav Immun"},{"key":"3649_CR133","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","volume":"175","author":"C Bartels","year":"2018","unstructured":"Bartels C, Wagner M, Wolfsgruber S, Ehrenreich H, Schneider A, for the Alzheimer\u2019s Disease Neuroimaging Initiative. Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer\u2019s dementia in individuals with previous depression. AJP. 2018;175:232\u201341.","journal-title":"AJP"},{"key":"3649_CR134","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3390\/ph14090894","volume":"14","author":"J Kornhuber","year":"2021","unstructured":"Kornhuber J, Gulbins E. New molecular targets for antidepressant drugs. Pharmaceuticals. 2021;14:894.","journal-title":"Pharmaceuticals"},{"key":"3649_CR135","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/add.14935","volume":"115","author":"J Li","year":"2020","unstructured":"Li J, Wang H, Li M, Shen Q, Li X, Zhang Y, et al. Effect of alcohol use disorders and alcohol intake on the risk of subsequent depressive symptoms: a systematic review and meta\u2010analysis of cohort studies. Addiction. 2020;115:1224\u201343.","journal-title":"Addiction"},{"key":"3649_CR136","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1038\/s41380-023-02074-3","volume":"28","author":"CP M\u00fcller","year":"2023","unstructured":"M\u00fcller CP, Schumann G, Rehm J, Kornhuber J, Lenz B. Self-management with alcohol over lifespan: psychological mechanisms, neurobiological underpinnings, and risk assessment. Mol Psychiatry. 2023;28:2683\u201396.","journal-title":"Mol Psychiatry"},{"key":"3649_CR137","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1017\/S0140525X1100135X","volume":"34","author":"CP M\u00fcller","year":"2011","unstructured":"M\u00fcller CP, Schumann G. To use or not to use: Expanding the view on non-addictive psychoactive drug consumption and its implications. Behav Brain Sci. 2011;34:328\u201347.","journal-title":"Behav Brain Sci"},{"key":"3649_CR138","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1471-4159.2009.05906.x","volume":"109","author":"A Heiseke","year":"2009","unstructured":"Heiseke A, Aguib Y, Riemer C, Baier M, Sch\u00e4tzl HM. Lithium induces clearance of protease resistant prion protein in prion\u2010infected cells by induction of autophagy. J Neurochem. 2009;109:25\u201334.","journal-title":"J Neurochem"},{"key":"3649_CR139","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1083\/jcb.200504035","volume":"170","author":"S Sarkar","year":"2005","unstructured":"Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol. 2005;170:1101\u201311.","journal-title":"J Cell Biol"},{"key":"3649_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02658-1","volume":"13","author":"D Loef","year":"2023","unstructured":"Loef D, Tendolkar I, Van Eijndhoven PFP, Hoozemans JJM, Oudega ML, Rozemuller AJM, et al. Electroconvulsive therapy is associated with increased immunoreactivity of neuroplasticity markers in the hippocampus of depressed patients. Transl Psychiatry. 2023;13:355.","journal-title":"Transl Psychiatry"},{"key":"3649_CR141","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.12659\/MSM.897765","volume":"22","author":"P Li","year":"2016","unstructured":"Li P, Hao X, Luo J, Lv F, Wei K, Min S. Propofol mitigates learning and memory impairment after electroconvulsive shock in depressed rats by inhibiting autophagy in the hippocampus. Med Sci Monit. 2016;22:1702\u20138.","journal-title":"Med Sci Monit"},{"key":"3649_CR142","doi-asserted-by":"publisher","first-page":"e96905","DOI":"10.1371\/journal.pone.0096905","volume":"9","author":"G Grosso","year":"2014","unstructured":"Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of Omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS ONE. 2014;9:e96905.","journal-title":"PLoS ONE"},{"key":"3649_CR143","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1038\/tp.2016.29","volume":"6","author":"RJT Mocking","year":"2016","unstructured":"Mocking RJT, Harmsen I, Assies J, Koeter MWJ, Ruh\u00e9 HG, Schene AH. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016;6:e756.","journal-title":"Transl Psychiatry"},{"key":"3649_CR144","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jpsychires.2016.02.023","volume":"77","author":"FB Schuch","year":"2016","unstructured":"Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B. Exercise as a treatment for depression: A meta-analysis adjusting for publication bias. J Psychiatr Res. 2016;77:42\u201351.","journal-title":"J Psychiatr Res"},{"key":"3649_CR145","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fnut.2020.00094","volume":"7","author":"DZ Andreotti","year":"2020","unstructured":"Andreotti DZ, Silva JDN, Matumoto AM, Orellana AM, De Mello PS, Kawamoto EM. Effects of physical exercise on autophagy and apoptosis in aged brain: human and animal studies. Front Nutr. 2020;7:94.","journal-title":"Front Nutr"},{"key":"3649_CR146","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.bbrc.2018.05.084","volume":"501","author":"X Fang","year":"2018","unstructured":"Fang X, Ge K, Song C, Ge Y, Zhang J. Effects of n-3PUFAs on autophagy and inflammation of hypothalamus and body weight in mice. Biochem Biophys Res Commun. 2018;501:927\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"3649_CR147","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.4161\/auto.21327","volume":"8","author":"C He","year":"2012","unstructured":"He C, Sumpter R Jr., Levine B. Exercise induces autophagy in peripheral tissues and in the brain. Autophagy. 2012;8:1548\u201351.","journal-title":"Autophagy"},{"key":"3649_CR148","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3390\/nu10111695","volume":"10","author":"J Matta","year":"2018","unstructured":"Matta J, Czernichow S, Kesse-Guyot E, Hoertel N, Limosin F, Goldberg M, et al. Depressive symptoms and vegetarian diets: results from the constances cohort. Nutrients. 2018;10:1695.","journal-title":"Nutrients"},{"key":"3649_CR149","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jad.2018.09.072","volume":"244","author":"J Matta","year":"2019","unstructured":"Matta J, Hoertel N, Kesse-Guyot E, Plesz M, Wiernik E, Carette C, et al. Diet and physical activity in the association between depression and metabolic syndrome: Constances study. J Affect Disord. 2019;244:25\u201332.","journal-title":"J Affect Disord"},{"key":"3649_CR150","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/nu12092700","volume":"12","author":"J Matta","year":"2020","unstructured":"Matta J, Hoertel N, Airagnes G, Czernichow S, Kesse-Guyot E, Limosin F, et al. Dietary restrictions and depressive symptoms: longitudinal results from the constances cohort. Nutrients. 2020;12:2700.","journal-title":"Nutrients"},{"key":"3649_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02297-y","volume":"13","author":"B Guo","year":"2023","unstructured":"Guo B, Zhang M, Hao W, Wang Y, Zhang T, Liu C. Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression. Transl Psychiatry. 2023;13:5.","journal-title":"Transl Psychiatry"},{"key":"3649_CR152","doi-asserted-by":"publisher","first-page":"54","DOI":"10.33594\/000000200","volume":"27","author":"C M\u00fchle","year":"2019","unstructured":"M\u00fchle C, Bilbao Canalejas RD, Kornhuber J. Sphingomyelin synthases in neuropsychiatric health and disease. Neurosignals. 2019;27:54\u201376.","journal-title":"Neurosignals"},{"key":"3649_CR153","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","volume":"9","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010;9:883\u201397.","journal-title":"Nat Rev Drug Discov"},{"key":"3649_CR154","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","volume":"124","author":"R Van Doorn","year":"2012","unstructured":"Van Doorn R, Nijland PG, Dekker N, Witte ME, Lopes-Pinheiro MA, Van Het Hof B, et al. Fingolimod attenuates ceramide-induced blood\u2013brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol. 2012;124:397\u2013410.","journal-title":"Acta Neuropathol"},{"key":"3649_CR155","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jpsychires.2012.11.001","volume":"47","author":"A Demirkan","year":"2013","unstructured":"Demirkan A, Isaacs A, Ugocsai P, Liebisch G, Struchalin M, Rudan I, et al. Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study. J Psychiatr Res. 2013;47:357\u201362.","journal-title":"J Psychiatr Res"},{"key":"3649_CR156","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1038\/s41380-025-02893-6","volume":"30","author":"D Chestnykh","year":"2025","unstructured":"Chestnykh D, M\u00fchle C, Schumacher F, Kalinichenko LS, L\u00f6ber S, Gmeiner P, et al. Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Mol Psychiatry. 2025;30:2891\u2013906.","journal-title":"Mol Psychiatry"},{"key":"3649_CR157","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.addr.2020.04.009","volume":"159","author":"D Van Kruining","year":"2020","unstructured":"Van Kruining D, Luo Q, Van Echten-Deckert G, Mielke MM, Bowman A, Ellis S, et al. Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods. Adv Drug Deliv Rev. 2020;159:232\u201344.","journal-title":"Adv Drug Deliv Rev"},{"key":"3649_CR158","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamapsychiatry.2023.4096","volume":"81","author":"J Tomasik","year":"2024","unstructured":"Tomasik J, Harrison SJ, Rustogi N, Olmert T, Barton-Owen G, Han SYS, et al. Metabolomic biomarker signatures for bipolar and unipolar depression. JAMA Psychiatry. 2024;81:101.","journal-title":"JAMA Psychiatry"},{"key":"3649_CR159","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pnpbp.2018.06.003","volume":"86","author":"AR Brunoni","year":"2018","unstructured":"Brunoni AR, Padberg F, Vieira ELM, Teixeira AL, Carvalho AF, Lotufo PA, et al. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;86:211\u20137.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3649_CR160","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jama.2022.9805","volume":"328","author":"DW Oslin","year":"2022","unstructured":"Oslin DW, Lynch KG, Shih M-C, Ingram EP, Wray LO, Chapman SR, et al. Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder: The PRIME care randomized clinical trial. JAMA. 2022;328:151.","journal-title":"JAMA"},{"key":"3649_CR161","doi-asserted-by":"publisher","first-page":"e12623","DOI":"10.1002\/dad2.12623","volume":"16","author":"KF Moseholm","year":"2024","unstructured":"Moseholm KF, Cronj\u00e9 HT, Koch M, Fitzpatrick AL, Lopez OL, Otto MCDO, et al. Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study. Alz & Dem Diag Ass & Dis Mo. 2024;16:e12623.","journal-title":"Alz & Dem Diag Ass & Dis Mo"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03649-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:03:58Z","timestamp":1789117438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":161,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3649"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03649-6","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.H. is co-founder and scientific director of CERAMED, a company developing sphingolipid-based diagnostics and therapeutics under the French PACTE law public-private partnership. C.M. and J.K. are unpaid scientific advisors of CERAMED through an academic agreement with Universit\u00e4t Erlangen-N\u00fcrnberg. H.C. and M.S.R. are scientific consultants to CERAMED. This work received no funding from CERAMED or other industry sources. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}